pharma · Major Depressive Disorder (MDD) · Primary or advanced breast cancer LumA or ER+ Lobular subtypes.
Talon Biomarkers
Talion
Talion is a pharma organization headquartered in JP. Primary therapeutic focus areas include Major Depressive Disorder (MDD), Primary or advanced breast cancer LumA or ER+ Lobular subtypes., non-small cell lung cancer (N
Company details
- Status
- Public
- HQ
- Whippany, USA
- Founded
- 2021
- Employees
- 7
- Programs
- 5
- Drugs
- 44
- Patents
- 0
Quick answer
Talion is a pharma organization headquartered in JP. Primary therapeutic focus areas include Major Depressive Disorder (MDD), Primary or advanced breast cancer LumA or ER+ Lobular subtypes., non-small cell lung cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer. NovaPharmaNews links 5 clinical program(s), 33 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (3), phase 3 (2).
Company snapshot
Talon Biomarkers is a biomarker discovery engine built to capture indicators of disease and therapy from a sea of immune cells. We're fueled by a uniquely powerful and robust technology platform that changes the old-school paradigm of how a contract-research organization works. We are your partners in science, helping with experimental and study design, data acquisition, analysis, and even interpr
- 1 approved product(s) across US/EU regulatory metadata.
- 5 active pipeline program(s) linked via ClinicalTrials.gov.
- 5 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Talon Biomarkers. Not investment advice.
Top assets
Lead pipeline drugs
- Marketed / approved
- Marketed / approved
- Marketed / approved
- Marketed / approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 2
- Phase 2
Momentum
Proprietary activity score for Talon Biomarkers.
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Talon Biomarkers.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Talon Biomarkers?
-
Is Talon Biomarkers publicly traded?
-
What drugs does Talon Biomarkers develop or market?
-
What are the latest developments for Talon Biomarkers?
-
What therapeutic areas does Talon Biomarkers focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.